UNLIMITED TURBO LONG - ARGENX SE Stock

Certificat

X0HAB

NL0015493214

Market Closed - Euronext Paris 12:30:01 2024-05-17 pm EDT
11.86 EUR -3.34% Intraday chart for UNLIMITED TURBO LONG - ARGENX SE
Current month-8.87%
1 month-0.84%
Date Price Change
24-05-17 11.84 -3.58%
24-05-16 12.28 -0.16%
24-05-15 12.3 +14.47%
24-05-14 10.74 -8.58%
24-05-13 11.75 -6.76%

Real-time Euronext Paris

Last update May 17, 2024 at 12:30 pm EDT

More quotes

Static data

Product typeCertificat Turbo
Buy / SellCALL
Underlying ARGENX SE
IssuerLogo Issuer BNP Paribas BNP Paribas
X0HAB
ISINNL0015493214
Date issued 2020-09-16
Strike 227
Maturity Unlimited
Parity 10 : 1
Emission price 0.66
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 28.5
Lowest since issue 1.145

Company Profile

argenx SE is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx SE aims to translate immunology breakthroughs into a world-class portfolio of novel antibody-based medicines. argenx SE is evaluating efgartigimod in multiple serious autoimmune diseases, and cusatuzumab in hematological cancers in collaboration with Janssen. argenx SE is also advancing several earlier stage experimental medicines within its therapeutic franchises. argenx SE has offices in Belgium, the United States, and Japan.
Sector
-
More about the company

Ratings for argenx SE

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: argenx SE

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
339.9 EUR
Average target price
432.9 EUR
Spread / Average Target
+27.35%
Consensus
  1. Stock Market
  2. Certificates
  3. X0HAB Certificat
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW